A breakthrough in HIV prevention has emerged with the recent approval of lenacapavir, marketed as Yeztugo, by the Food and Drug Administration (FDA) on June 18,...
The Food and Drug Administration (FDA) has approved lenacapavir, a groundbreaking injection developed by Gilead Sciences for the prevention of HIV. This treatment, branded as Yeztugo,...
The AIDS Healthcare Foundation (AHF) has rallied over 80 organizations to express strong opposition to Gilead Sciences’ recent decision to implement high-single digit price increases on...
